Maze Therapeutics Inc.
MAZE | NASDAQ
$28.35
+$5.96 (+26.62%)
Sep 22, 2026, 2:46 PM ET · Market open
Market Data
Market Cap $1.24B
Enterprise Value $849.56M
Beta 2.16
Average Volume 528.55K
Shares Outstanding (Diluted) 59M
Shares Change YoY 34.54%
Institutional Ownership 95.88%
Exchange NASDAQ
ISIN US5787841007
Price Performance
Price Change 1M -23.7%
Price Change 3M -15.2%
Price Change 6M -29.4%
Price Change YTD -43.7%
Price Change 1Y -5.4%
Price Change 3Y 40.4%
Price Change 5Y 40.4%
1M CAGR (ann.) -21.9%
1Y CAGR (ann.) -4.6%
5Y CAGR (ann.) N/A
All-Time CAGR 23.0%
Valuation
PE Ratio -8.17
Forward PE N/A
PEG Ratio 0.16
Forward PEG -0.50
PS Ratio 61.96
Forward PS 89.10
PB Ratio 2.73
P/FCF Ratio -11.60
P/Adj. FCF Ratio -9.31
P/OCF Ratio -12.37
EV/Sales 42.48
EV/EBIT -6.45
EV/EBITDA -6.52
EV/FCF -7.95
Earnings Yield -12.2%
FCF Yield -8.6%
Adj. FCF Yield -10.7%
Financial Health
Net Cash $389.62M
Total Debt $21.46M
Cash & Short-Term Investments $411.09M
Total Assets $531.63M
Current Ratio 18.31
Quick Ratio 18.31
Debt / Equity Ratio 0.13
Debt / EBITDA -0.16
Debt / FCF -0.20
OCF / Debt -4.96
Interest Coverage -81.03
Altman Z-Score 8.12
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 95.3%
Operating Profit Margin -728.1%
EBITDA Margin -651.4%
Net Profit Margin -668.0%
FCF Margin -534.2%
Adj. FCF Margin -665.4%
SBC / Revenue 131.2%
SBC Impact (per share) -24.6%
Returns
Return on Assets -25.1%
Return on Equity -34.9%
Return on Invested Capital -28.4%
Return on Capital Employed -28.6%
Return on Tangible Assets -25.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 0.0%
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -21.5%
EPS CAGR 5Y N/A
EPS CAGR 10Y N/A
FCF CAGR 3Y -30.5%
FCF CAGR 5Y N/A
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y -13.3%
Revenue Growth Next 3Y 36.6%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.79
EPS Growth Est (next Q) 19.7%
Revenue Est (next Q) $333.33K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $64
Price Target Upside 185.8%
Cash Flow
Operating Cash Flow $-106.54M
Free Cash Flow $-106.84M
Adj. Free Cash Flow $-133.07M
FCF Per Share -$1.81
OCF Per Share -$1.81
OCF/S Ratio -532.7%
Income Statement
Revenue $20M
Gross Profit $19.06M
Operating Income $-145.61M
EBITDA $-130.28M
Net Income $-133.59M
EPS (Diluted) -$2.74
Revenue / Employee $141.84K
Profit / Employee $-947.45K
Employees 141
Add to Watchlist
Select watchlists to add or remove MAZE